Publications
95
Citations
741
Est. group size
~12
Recurring co-author estimate
Active years
24
Publishing since 2003
Jessica S. Fortin's research focuses on protein misfolding and aggregation diseases, particularly involving proteins like alpha-synuclein, tau, and amyloid that are linked to neurodegenerative conditions such as Alzheimer's and Parkinson's disease. Her work spans basic biochemistry (studying protein structure and aggregation using mass spectrometry), drug discovery (designing small molecules to block harmful protein clumping), and veterinary medicine (including studies on amyloidosis and pituitary disease in horses). This combination suggests a translational approach connecting molecular-level protein science to disease diagnosis and therapeutic development across both human and animal contexts.
Publication output rose notably from 2017-2019 to a higher and fairly steady pace from 2020 through 2025, suggesting a period of growth followed by sustained, active output over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Differences in α-synuclein conformational states in physiologically relevant pH/Na <sup>+</sup> concentrations and ammonium acetate solutions unveiled by native mass spectrometry
The Analyst · 2026
- Plasma adrenocorticotropin concentrations vary with assay used in equids with and without pituitary pars intermedia dysfunction
SSRN Electronic Journal · 2026
- Utilizing image analysis by optical density to evaluate changes in hematoxylin and eosin staining quality after reagent overuse
Journal of Histotechnology · 2025
- Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein Aggregates
ACS Omega · 2025
- Classification of amyloidosis and protein misfolding disorders in animals 2024: A review on pathology and diagnosis
Veterinary Pathology · 2024
- Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease Therapeutics
ACS Chemical Neuroscience · 2024
- Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α-synuclein and 2N4R tau
Bioorganic & Medicinal Chemistry · 2024
- Corrigendum to “Revisiting misfolding propensity of serum amyloid A1: Special focus on the signal peptide region” [Biochem. Biophys. Rep. 31 (2022) 1–9/101284]
Biochemistry and Biophysics Reports · 2024
- Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
Drug Discovery Today · 2023
- Lumbar vertebral bone density is decreased in horses with pituitary pars intermedia dysfunction
Equine Veterinary Journal · 2023
- Author response for "Lumbar vertebral bone density is decreased in horses with pituitary pars intermedia dysfunction"
2023
- Author response for "Lumbar vertebral bone density is decreased in horses with pituitary pars intermedia dysfunction"
2023
- Revisiting Small Molecule Inhibitors of Amyloid‐β Aggregation
The FASEB Journal · 2022
- Toxic/metabolic diseases of the nervous system
Elsevier eBooks · 2022
- Anti-fibrillization effects of sulfonamide derivatives on α-synuclein and hyperphosphorylated tau isoform 1N4R
Journal of Molecular Structure · 2022
- The FASEB Journal×13
- Biochemistry and Biophysics Reports×5
- ACS Omega×4
- Elsevier eBooks×3
- Veterinary Medicine and Science×3
- Taiwo A. Ademoye
Medicine · Purdue University West Lafayette
- Hossein Ashrafian
Medicine · The Ohio State University
- Upasana Ganguly
Medicine · Indiana University
- Greg T. Sutherland
Medicine · The Ohio State University
- Bernardino Ghetti
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile